PubMed:10384153 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T1","span":{"begin":0,"end":82},"obj":"Sentence"},{"id":"T2","span":{"begin":83,"end":253},"obj":"Sentence"},{"id":"T3","span":{"begin":254,"end":548},"obj":"Sentence"},{"id":"T4","span":{"begin":549,"end":672},"obj":"Sentence"},{"id":"T5","span":{"begin":673,"end":814},"obj":"Sentence"},{"id":"T6","span":{"begin":815,"end":868},"obj":"Sentence"},{"id":"T7","span":{"begin":869,"end":977},"obj":"Sentence"},{"id":"T8","span":{"begin":978,"end":1082},"obj":"Sentence"},{"id":"T9","span":{"begin":1083,"end":1226},"obj":"Sentence"},{"id":"T10","span":{"begin":1227,"end":1437},"obj":"Sentence"},{"id":"T11","span":{"begin":1438,"end":1732},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":82},"obj":"Sentence"},{"id":"T2","span":{"begin":83,"end":253},"obj":"Sentence"},{"id":"T3","span":{"begin":254,"end":548},"obj":"Sentence"},{"id":"T4","span":{"begin":549,"end":672},"obj":"Sentence"},{"id":"T5","span":{"begin":673,"end":814},"obj":"Sentence"},{"id":"T6","span":{"begin":815,"end":868},"obj":"Sentence"},{"id":"T7","span":{"begin":869,"end":977},"obj":"Sentence"},{"id":"T8","span":{"begin":978,"end":1082},"obj":"Sentence"},{"id":"T9","span":{"begin":1083,"end":1226},"obj":"Sentence"},{"id":"T10","span":{"begin":1227,"end":1437},"obj":"Sentence"},{"id":"T11","span":{"begin":1438,"end":1732},"obj":"Sentence"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}

{"project":"jnlpba-st-training","denotations":[{"id":"T1","span":{"begin":8,"end":21},"obj":"cell_type"},{"id":"T2","span":{"begin":281,"end":294},"obj":"cell_type"},{"id":"T3","span":{"begin":414,"end":441},"obj":"cell_type"},{"id":"T4","span":{"begin":566,"end":574},"obj":"protein"},{"id":"T5","span":{"begin":597,"end":628},"obj":"cell_type"},{"id":"T6","span":{"begin":675,"end":694},"obj":"cell_line"},{"id":"T7","span":{"begin":751,"end":763},"obj":"protein"},{"id":"T8","span":{"begin":769,"end":791},"obj":"cell_type"},{"id":"T9","span":{"begin":869,"end":878},"obj":"cell_line"},{"id":"T10","span":{"begin":936,"end":945},"obj":"protein"},{"id":"T11","span":{"begin":964,"end":967},"obj":"protein"},{"id":"T12","span":{"begin":1093,"end":1097},"obj":"protein"},{"id":"T13","span":{"begin":1264,"end":1284},"obj":"cell_type"},{"id":"T14","span":{"begin":1335,"end":1344},"obj":"cell_type"},{"id":"T15","span":{"begin":1359,"end":1368},"obj":"protein"},{"id":"T16","span":{"begin":1377,"end":1381},"obj":"protein"},{"id":"T17","span":{"begin":1414,"end":1422},"obj":"protein"},{"id":"T18","span":{"begin":1427,"end":1436},"obj":"protein"},{"id":"T19","span":{"begin":1460,"end":1479},"obj":"cell_type"},{"id":"T20","span":{"begin":1600,"end":1633},"obj":"cell_type"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}

{"project":"genia-medco-coref","denotations":[{"id":"C1","span":{"begin":114,"end":139},"obj":"NP"},{"id":"C2","span":{"begin":198,"end":222},"obj":"NP"},{"id":"C3","span":{"begin":376,"end":378},"obj":"NP"},{"id":"C4","span":{"begin":445,"end":493},"obj":"NP"},{"id":"C5","span":{"begin":501,"end":538},"obj":"NP"},{"id":"C6","span":{"begin":650,"end":658},"obj":"NP"},{"id":"C7","span":{"begin":663,"end":671},"obj":"NP"},{"id":"C8","span":{"begin":673,"end":694},"obj":"NP"},{"id":"C9","span":{"begin":713,"end":717},"obj":"NP"},{"id":"C10","span":{"begin":899,"end":919},"obj":"NP"},{"id":"C11","span":{"begin":936,"end":945},"obj":"NP"},{"id":"C12","span":{"begin":1034,"end":1053},"obj":"NP"},{"id":"C13","span":{"begin":1230,"end":1242},"obj":"NP"},{"id":"C14","span":{"begin":1315,"end":1344},"obj":"NP"},{"id":"C15","span":{"begin":1345,"end":1349},"obj":"NP"},{"id":"C16","span":{"begin":1427,"end":1436},"obj":"NP"},{"id":"C18","span":{"begin":1485,"end":1517},"obj":"NP"},{"id":"C17","span":{"begin":1460,"end":1517},"obj":"NP"},{"id":"C19","span":{"begin":1555,"end":1560},"obj":"NP"},{"id":"C20","span":{"begin":1591,"end":1633},"obj":"NP"},{"id":"C21","span":{"begin":1634,"end":1638},"obj":"NP"},{"id":"C22","span":{"begin":1729,"end":1731},"obj":"NP"}],"relations":[{"id":"R1","pred":"coref-ident","subj":"C3","obj":"C1"},{"id":"R2","pred":"coref-ident","subj":"C6","obj":"C4"},{"id":"R3","pred":"coref-ident","subj":"C7","obj":"C5"},{"id":"R4","pred":"coref-pron","subj":"C9","obj":"C8"},{"id":"R5","pred":"coref-ident","subj":"C10","obj":"C7"},{"id":"R6","pred":"coref-ident","subj":"C12","obj":"C2"},{"id":"R7","pred":"coref-ident","subj":"C13","obj":"C6"},{"id":"R8","pred":"coref-relat","subj":"C15","obj":"C14"},{"id":"R9","pred":"coref-ident","subj":"C16","obj":"C11"},{"id":"R10","pred":"coref-ident","subj":"C18","obj":"C13"},{"id":"R11","pred":"coref-relat","subj":"C19","obj":"C17"},{"id":"R12","pred":"coref-relat","subj":"C21","obj":"C20"},{"id":"R13","pred":"coref-ident","subj":"C22","obj":"C3"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}

{"project":"pubmed-sentences-benchmark","denotations":[{"id":"S1","span":{"begin":0,"end":82},"obj":"Sentence"},{"id":"S2","span":{"begin":83,"end":253},"obj":"Sentence"},{"id":"S3","span":{"begin":254,"end":548},"obj":"Sentence"},{"id":"S4","span":{"begin":549,"end":672},"obj":"Sentence"},{"id":"S5","span":{"begin":673,"end":814},"obj":"Sentence"},{"id":"S6","span":{"begin":815,"end":868},"obj":"Sentence"},{"id":"S7","span":{"begin":869,"end":977},"obj":"Sentence"},{"id":"S8","span":{"begin":978,"end":1082},"obj":"Sentence"},{"id":"S9","span":{"begin":1083,"end":1226},"obj":"Sentence"},{"id":"S10","span":{"begin":1227,"end":1437},"obj":"Sentence"},{"id":"S11","span":{"begin":1438,"end":1732},"obj":"Sentence"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}

{"project":"GENIAcorpus","denotations":[{"id":"T1","span":{"begin":0,"end":7},"obj":"other_name"},{"id":"T2","span":{"begin":8,"end":21},"obj":"cell_type"},{"id":"T3","span":{"begin":55,"end":81},"obj":"other_name"},{"id":"T4","span":{"begin":114,"end":134},"obj":"other_name"},{"id":"T5","span":{"begin":136,"end":138},"obj":"other_name"},{"id":"T6","span":{"begin":281,"end":294},"obj":"cell_type"},{"id":"T7","span":{"begin":376,"end":378},"obj":"other_name"},{"id":"T8","span":{"begin":414,"end":441},"obj":"cell_type"},{"id":"T9","span":{"begin":445,"end":453},"obj":"multi_cell"},{"id":"T10","span":{"begin":491,"end":493},"obj":"other_name"},{"id":"T11","span":{"begin":510,"end":538},"obj":"multi_cell"},{"id":"T12","span":{"begin":566,"end":574},"obj":"protein_family_or_group"},{"id":"T13","span":{"begin":597,"end":628},"obj":"cell_type"},{"id":"T14","span":{"begin":650,"end":658},"obj":"multi_cell"},{"id":"T15","span":{"begin":675,"end":694},"obj":"cell_line"},{"id":"T16","span":{"begin":751,"end":763},"obj":"protein_family_or_group"},{"id":"T17","span":{"begin":769,"end":791},"obj":"cell_type"},{"id":"T18","span":{"begin":869,"end":878},"obj":"cell_line"},{"id":"T19","span":{"begin":936,"end":945},"obj":"protein_family_or_group"},{"id":"T20","span":{"begin":964,"end":967},"obj":"protein_family_or_group"},{"id":"T21","span":{"begin":1034,"end":1053},"obj":"other_name"},{"id":"T22","span":{"begin":1070,"end":1072},"obj":"other_name"},{"id":"T23","span":{"begin":1073,"end":1081},"obj":"multi_cell"},{"id":"T24","span":{"begin":1093,"end":1097},"obj":"protein_molecule"},{"id":"T25","span":{"begin":1126,"end":1145},"obj":"other_name"},{"id":"T26","span":{"begin":1162,"end":1170},"obj":"multi_cell"},{"id":"T27","span":{"begin":1217,"end":1225},"obj":"multi_cell"},{"id":"T28","span":{"begin":1234,"end":1242},"obj":"multi_cell"},{"id":"T29","span":{"begin":1264,"end":1268},"obj":"protein_molecule"},{"id":"T30","span":{"begin":1335,"end":1344},"obj":"cell_type"},{"id":"T31","span":{"begin":1359,"end":1368},"obj":"protein_molecule"},{"id":"T32","span":{"begin":1377,"end":1381},"obj":"protein_molecule"},{"id":"T33","span":{"begin":1414,"end":1422},"obj":"protein_family_or_group"},{"id":"T34","span":{"begin":1427,"end":1436},"obj":"protein_family_or_group"},{"id":"T35","span":{"begin":1460,"end":1479},"obj":"cell_type"},{"id":"T36","span":{"begin":1485,"end":1493},"obj":"multi_cell"},{"id":"T37","span":{"begin":1515,"end":1517},"obj":"other_name"},{"id":"T38","span":{"begin":1530,"end":1551},"obj":"other_name"},{"id":"T39","span":{"begin":1600,"end":1633},"obj":"cell_type"},{"id":"T40","span":{"begin":1678,"end":1725},"obj":"other_name"},{"id":"T41","span":{"begin":1729,"end":1731},"obj":"other_name"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}

{"project":"PubmedHPO","denotations":[{"id":"T1","span":{"begin":114,"end":134},"obj":"HP_0001370"},{"id":"T2","span":{"begin":125,"end":134},"obj":"HP_0001369"}],"text":"Altered memory T cell differentiation in patients with early rheumatoid arthritis.\nThe chronic immune response in rheumatoid arthritis (RA) might be driven by activated Th1 cells without sufficient Th2 cell differentiation to down-modulate inflammation. To test whether disordered memory T cell differentiation contributes to the typical Th1-dominated chronic inflammation in RA we investigated differentiation of resting CD4+ memory T cells in patients with early (6 wk to 12 mo) untreated RA and in age- and sex-matched healthy controls in vitro. No difference in cytokine secretion profiles of freshly isolated memory T cells was detected between patients and controls. A cell culture system was then employed that permitted the differentiation of Th effectors from resting memory T cells by short term priming. Marked differences were found in response to priming. Th2 cells could be induced in all healthy controls by priming with anti-CD28 in the absence of TCR ligation. By contrast, priming under those conditions resulted in Th2 differentiation in only 9 of 24 RA patients. Exogenous IL-4 could overcome the apparent Th2 differentiation defect in seven patients but was without effect in the remaining eight patients. In all patients a marked decrease in IL-2-producing cells and a significant increase in well-differentiated Th1 cells that produced IFN-gamma but not IL-2 were evident after priming with anti-CD3 and anti-CD28. The data suggest that CD4+ memory T cells from patients with early untreated RA manifest an intrinsic abnormality in their ability to differentiate into specific cytokine-producing effector cells that might contribute to the characteristic Th1-dominated chronic (auto)immune inflammation in RA."}